Eliminate Viral Hepatitis

Each year, around 630 Australians and 500,000 people globally die from hepatitis C-related causes.

Eliminating hepatitis C virus (HCV) in Australia is now a possibility, with the listing of direct-acting antiviral (DAA) drugs on the PBS. But this is one step in the path towards elimination.

Burnet will also make a major contribution in global efforts to eliminate hepatitis B & C as major health threats. This includes supporting vital research underway by our researchers to create a novel, effective, low-cost HCV vaccine suitable for resource-constrained countries.

Burnet Institute’s Eliminate Viral Hepatitis strategy is focussed on:

  • Achieving a 50 percent reduction in hepatitis C prevalence in Australia by 2020.
  • Supporting the achievement of the WHO’s hepatitis C elimination targets in Australia before 2030 with key partners.
  • Working towards Global WHO viral hepatitis elimination strategy by addressing diagnosis, delivery of direct-acting antivirals, prevention and vaccine development.

Working together, with research organisations, governments, the community and affected populations, Burnet will help change the course of hepatitis C infection and its impact as a public health threat.

Hepatitis C virus (HCV) affects more than 250,000 Australians resulting in up to 630 deaths from liver cancer and liver failure each year. Globally, more than 500,000 people die from HCV-related causes.

The ambitious journey to eliminate viral hepatitis has begun.

Download

Contact Details

Professor Margaret Hellard AM

Deputy Director (Programs); Adjunct Professor, Monash University, DEPM.

Telephone

+61385062304

Email

margaret.hellard@burnet.edu.au


Projects

Latest News

  • 27 February, 2019

    Img 1656 135x132

    At the forefront of hepatitis elimination

    Professor Margaret Hellard appointed co-Chair of a World Health Organization Global Partners Meeting on hepatitis.

  • 20 February, 2019

    Photo 2019 02 19 12 27 59x 135x132

    New PNG collaboration

    Burnet Institute is collaborating with Papua New Guinea’s National Department of Health to improve health evidence, services and outcomes in PNG.

Upcoming Events

  • 04 September, 2019

    Sunset 634341 1920 135x132

    Contemporary Drug Problems Conference

    Professor Mark Stoové is a member of the organising committee for the 2019 Contemporary Drug Problems Conference in Prato, Italy.

  • 11 September, 2019

    Inhsu logo 135x132

    INHSU 2019

    Burnet Institute is a Conference Collaborator for the INHSU symposium from 11-13 September 2019 in Montreal, Canada.